Saint Luke’s Marion Bloch Neuroscience Institute announces 2018 Stroke & Cerebrovascular Conference
Kansas City, MO KANSAS CITY, Mo. (PRWEB) March 20, 2018 -- Saint Luke’s Marion Bloch Neuroscience Institute, the Kansas City region’s premier neuroscience institute, in conjunction with the Institute for International Medicine (INMED) and Saint Luke’s Hospital of Kansas City, will present its fourth annual Stroke & Cerebrovascular Conference on Friday, June 1, 2018 at the Overland Park Convention Center in Overland Park, Kansas.
The informative program will focus on the multidisciplinary approach to patients with stroke, including prevention, imaging, and a variety of treatment modalities from pre-hospital to operating room. The conference will feature presentations by Saint Luke’s faculty members, as well as special guest presenters.
“Saint Luke’s is committed to providing the best evidence-based treatment for stroke. In recent years, there have been significant advances in the diagnosis and treatment of stroke,” said Karin E. Olds, MD, Stroke Medical Director of the Neuroscience Institute and conference course director. “This program will emphasize the evidence-based strategy for current treatment and leading-edge research, as well as advances in medical and neuro interventional approaches to stroke.”
Presenters will speak on a variety of topics, including:
- Interactions between vascular risk factors and Alzheimer’s disease (Costantino Iadecola, MD, Director of the Feil Family Brain and Mind Research Institute, Weill Cornell Medical College)
- Advances in treatment of acute ischemic stroke through image guided interventional revascularization therapy (Mayank Goyal, MD, Director of Research, University of Calgary, Seaman Family MR Research Centre)
- Advances in stroke prevention in patients with Atrial Fibrillation (Kenneth C. Huber, MD, Co-executive Medical Director, Saint Luke’s Mid America Heart Institute)
- Advances in evaluation and treatment of Moya Moya disease (Gavin Britz, MD, Co-Director of Houston Methodist Neurological Institute)
- Challenges of treating a wake-up stroke in the aftermath of DAWN (Karin E. Olds, MD, Stroke Medical Director, Saint Luke’s Marion Bloch Neuroscience Institute)
- The role of PFO closure in stroke prevention (John Thomas Saxon, MD, Saint Luke’s Cardiovascular Consultants)
- Advances in acute stroke imaging (Naveed Akhtar, MD, Interventional Neuroradiologist, Saint Luke’s Hospital)
- Transitional systems of care for stroke patients and reduction of readmissions (Angela Hawkins, RN, MPH, System Stroke Program Manager, Saint Luke’s Marion Bloch Neuroscience Institute)
- Unusual Causes of Stroke: Diagnostic and Treatment Challenge (Suzanne C. Crandall, DO, Neurologist, Saint Luke’s Marion Bloch Neuroscience institute)
The conference has been planned and implemented in accordance with the Essential Areas and Policies of the Missouri State Medical Association through the joint providership of INMED and Saint Luke’s Hospital of Kansas City. Continuing education credits will be offered to physicians, physician assistants, advanced nurse practitioners and other healthcare professionals with an interest in neurology. The conference benefits primary care physicians, neurologists, neurointensivists, neuroradiologists, physiatrists, neuroscience nurses, and EMS providers. For more information and to register, visit https://eventmobi.com/2018stroke/.
About Saint Luke’s Marion Bloch Neuroscience Institute
Saint Luke’s Marion Bloch Neuroscience Institute (SLMBNI) is a comprehensive center for neuroscience research, education, and evidence-based medicine that combines faculty in neurology, neurosurgery, interventional neuroradiology, neurotology, psychiatry, and physical medicine and rehabilitation. The only dedicated neuroscience hospital in Kansas City, SLMNBI was nationally ranked in the top 50 for neurology and neurosurgery by U.S. News & World Report in 2017-2018. Together SLMBNI faculty provide patient-centered, leading-edge care to thousands of patients from all over the country. As a member of Saint Luke’s Health System, SLMBNI is a global leader in utilizing both drug and mechanical interventions to reverse the permanent and debilitating effects of ischemic stroke. Its legacy of innovation began in 1993 when doctors performed one of the world’s first intra-arterial stroke reversal procedures. Since then, Saint Luke’s specialists have continued to pioneer new stroke treatments and reverse strokes in thousands of patients through its network of stroke centers. Located in Kansas City, Mo., SLMBNI brings together a team of highly specialized neuroscientists to provide comprehensive treatment for the most complex neurological diseases, including stroke, epilepsy, brain tumors, Parkinson’s and Alzheimer’s diseases, multiple sclerosis, headaches and facial pain, as well as aneurysms and intracerebral hemorrhages. The Institute’s multispecialty team provides the latest in minimally invasive spinal surgical techniques for the treatment of acute and chronic back pain. SLMBNI strives to be a national leader in neurological treatment and care by advancing clinical research and evidence-based clinical practice.
Saint Luke’s Health System
Saint Luke’s Health System consists of 10 area hospitals and campuses, and several primary and specialty care practices, and provides a range of inpatient, outpatient, and home care services. Founded as a faith-based, not-for-profit organization, our mission includes a commitment to the highest levels of excellence in health care and the advancement of medical research and education. The health system is an aligned organization in which the physicians and hospitals assume responsibility for enhancing the physical, mental, and spiritual health of people in the Kansas City metropolitan area and the surrounding region.
Michelle Manuel, Saint Luke's Health System, +1 (816) 502-8533, [email protected]
Share this article